A recent report published by Infinium Global Research on 3D
bioprinting market provides an in-depth analysis of segments and sub-segments in
the global as well as regional 3D bioprinting market. The study also highlights
the impact of drivers, restraints, and macro indicators on the global and
regional 3D bioprinting market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecast and dollar values of the global 3D bioprinting market. According to the report, the global 3D
bioprinting market is projected to grow at a CAGR of 21.40% over the forecast
period of 2019-2025.
Technological advancements in the field of manufacturing have
evolved the medical and pharmaceutical industries. One of the novel manufacturing
techniques is 3D printing and 3D bioprinting is the application of 3D bioprinting
in the field of medical and pharmaceuticals. The 3D bioprinting market is
relatively new and it is highly fragmented in nature with a number of market
players competing to hold a leading position in the market. The key players in
the market including Organovo Holdings Inc., Cellink AB, Cyfuse Biomedical
K.K., 3 Dynamics Systems Ltd., Aspect Biosystems Ltd., and others are focusing
on strategic collaborations, acquisitions, agreements, and novel product
launch to compete in the market. Recently, Organovo Holding, Inc. announced a
partnership with L’Oreal for the development of skin tissue with its NovoGen
Bioprinting Platform. On the other hand aspect, Biosystems made a collaboration
with the Institute for Technology-Inspired Regenerative Medicine (MERLN) at
Maastricht University in the Netherlands to develop kidney tissue by the head
of bioprinting research.
The rise in the prevalence of chronic diseases such as cancers and
degenerative diseases is the major factor driving the global 3D bioprinting
market. By using 3D bioprinting techniques, tissues are regenerated to treat
cancers and other diseases. Furthermore, an increase in R&D investment in
the field of biotechnology is contributing to the growth of the global 3D
bioprinting market. Additionally, government initiatives for improving
healthcare are also contributing to the growth of the 3D bioprinting market.
However, the dearth of skilled professionals is hampering the growth of the
global 3D bioprinting market. Nonetheless, the trend of personalized medicine
is anticipated to provide favorable opportunities for companies in the 3D
bioprinting market.
Region-wise, North America region dominated the global 3D
bioprinting market, accounting for the largest share in the market. The large
share of the region attributed to the increase in the geriatric population, the
presence of major market players, sophisticated healthcare infrastructure and
high investment in R&D to develop 3D printing technology. On the other
hand, the 3D bioprinting market in the Asia-Pacific region is anticipated to
register the highest rate of growth. The fastest growth of the market in this
region attributes to a large population base suffering from chronic diseases,
and the increasing number of government initiatives to improve healthcare.
The report on the global 3D bioprinting market covers segments such as
technology, material, application, and end user. On the basis of technology,
the sub-markets include microextrusion bioprinting, inkjet 3D bioprinting,
laser-assisted bioprinting, and magnetic 3D bioprinting. On the basis of
material, the sub-markets include living cells, hydrogels, extracellular
matrices, and other materials. On the basis of application, the sub-markets
include research applications, clinical applications, and other applications.
On the basis of end user, the sub-markets include pharmaceutical &
biotechnology companies, research organizations, and other end users.
The report provides profiles of the companies in the market such
as Organovo Holdings Inc., Cellink AB, Luxexcel Group B.V., Cyfuse Biomedical
K.K., Nano3D Biosciences, Inc., 3 Dynamics Systems Ltd., Aspect Biosystems
Ltd., EnvisionTEC GmbH, Allevi, FUJIFILM Wako Automation Corporation, and other
companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of 3D bioprinting market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.